Milestone Pharmaceuticals
Stock Forecast, Prediction & Price Target
Milestone Pharmaceuticals Financial Estimates
Milestone Pharmaceuticals Revenue Estimates
Milestone Pharmaceuticals EBITDA Estimates
Milestone Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $15M N/A | $5M -66.66% | $1M -80% | Avg: $4.15M Low: $1.35M High: $8.10M avg. 315% | Avg: $30M Low: $12.59M High: $54.58M avg. 622.89% | Avg: $114.35M Low: $48.01M High: $208.07M avg. 281.16% | Avg: $226.4M Low: $95.06M High: $411.95M avg. 97.98% |
Net Income
% change YoY
| $-42.63M N/A | $-57.13M -34.01% | $-59.68M -4.46% | Avg: $-52.51M Low: $-80.92M High: $-30.13M avg. 12.01% | Avg: $-27.49M Low: $-56.78M High: $-6.75M avg. 47.64% | Avg: $13.74M Low: $3.37M High: $28.39M avg. 149.99% | Avg: $79.89M Low: $19.64M High: $165.02M avg. 481.25% |
EBITDA
% change YoY
| $-42.98M N/A | $-59.64M -38.76% | $-56.84M 4.68% | Avg: $-829.99K Low: $-1.62M High: $-270.16K avg. 98.53% | Avg: $-5.99M Low: $-10.91M High: $-2.51M avg. -622.89% | Avg: $-22.86M Low: $-41.61M High: $-9.60M avg. -281.16% | Avg: $-45.27M Low: $-82.39M High: $-19.01M avg. -97.98% |
EPS
% change YoY
| -$1.02 N/A | -$1.35 -32.35% | -$1.39 -2.96% | Avg: -$1.22 Low: -$1.88 High: -$0.7 avg. 12.05% | Avg: -$0.64 Low: -$1.32 High: -$0.16 avg. 47.64% | Avg: $0.32 Low: $0.08 High: $0.66 avg. 150% | Avg: $1.86 Low: $0.46 High: $3.84 avg. 481.25% |
Operating Expenses
% change YoY
| $58.07M N/A | $64.64M 11.31% | $62.09M -3.93% | Avg: $32.20M Low: $10.48M High: $62.88M avg. -48.14% | Avg: $232.77M Low: $97.74M High: $423.55M avg. 622.89% | Avg: $887.26M Low: $372.56M High: $1.61B avg. 281.16% | Avg: $1.75B Low: $737.64M High: $3.19B avg. 97.98% |
FAQ
What is Milestone Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 172.72% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -80.92M, average is -52.51M and high is -30.13M.
What is Milestone Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 329.26% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $1.35M, average is $4.15M and high is $8.10M.
What is Milestone Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 172.73% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.88, average is -$1.22 and high is $-0.70.